Revenue for the fourth quarter and full year 2024 was $47.5 million and $179.0 million, respectively. The MRD business, which contributed 85% of revenue in the fourth quarter and 81% of revenue in the ...

The Central California Blood Center has a new CEO to spearhead the nonprofit's mission of providing blood to area hospitals.

(Corrects third to last paragraph to say "the erosion from LOEs (loss of exclusivity)", not "from LOEs (levels of evidence)") ...

JonesResearch sees a buying opportunity in shares of Clearside Biomedical (CLSD) ahead of the company’s 2025 updates. The firm has a Buy rating ...

SAN JOSE, CALIFORNIA / ACCESS Newswire / February 11, 2025 / DuploCloud, the industry pioneer for DevOps automation and built-in compliance, will exhibit at ViVE 2025 in Nashville Feb. 16-19 (Booth #2 ...

The North American robotics market demonstrated minor overall growth in 2024, reflecting resilience and adaptability as ...

LYON, France, Feb. 11, 2025 /CNW/ -- Ziwig, a French biotech company committed to advancing women's health, announces the ...

The change would cap the maximum "indirect cost rate" research institutions charge the government at 15% of any given grant.

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

ABT Sportsline new RSQ8-LE (Legacy Edition) is capped at 125 copies, boasts more power than the Lamborghini Urus Performante, ...

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...